Certara, the provider of decision support technology and consulting services for optimising drug development and improving health outcomes, has announced the availability of D360 Express.
The R&D informatics platform provides scientific data integration, analysis, and visualisation and is specifically packaged for discovery scientists at small biopharmaceutical companies.
['The feedback that we have received from the 6,500 scientists using D360 has been overwhelmingly positive with regard to the platform’s ability to reduce research cycle times, enabling them to make quicker, more effective decisions,' said Certara chief executive officer Edmundo Muniz.
'Those scientists estimate that by using D360 they have been able to increase by more than 50 percent the time they spend performing pivotal scientific modelling and analysis instead of provisioning data.'
D360 is described as a scientifically intelligent data access solution for small molecule discovery scientists. It combines data from multiple cheminformatics and bioinformatics databases, allowing users to query those sources in a common GUI. D360 also enables those scientists to visualise their query results and make informed go/no go and next-step decisions.